Carfilzomib more effective and safer: new possibilities in myeloma treatment
An international team of scientists from Lenka Bešše's laboratory at the Department of Biology and colleagues from German and Swiss institutions have published joint research results on the effects of proteasome inhibition in multiple myeloma. These results offer new possibilities for using already approved and clinically available drugs.